HHMI Investigator Kevan Shokat and his lab are charting new therapies to outmaneuver drug resistance and better target common cancer cell mutations.

Researchers have identified a protein that could help develop safe and effective treatments for certain hard-to-treat bowel ...

Researchers at Cancer Research UK Scotland Institute have discovered a protein that could lead to new treatments for certain ...

The protein that protects tardigrade DNA from radiation and mutagenic chemicals was thought to be harmless, but can in fact ...

Sol-Gel Technologies is now rated 'Hold' due to reliance on a single late-stage asset and limited pipeline depth. Read the ...

Pancreatic cancer kills most patients within months of diagnosis, largely because symptoms don’t appear until the disease has already spread. Now, scientists at Tokyo University of Science have ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...

In a world where the immune system can be both hero and villain, three scientists have illuminated the path to taming its excesses. On October 6, 2025, ...

In mice, reducing FDX2 expression partially rescued neurological defects associated with frataxin loss without affecting survival or body weight. A recent study published in Nature suggests lowering ...

On the surface, cystic fibrosis and Tay-Sachs disease have nothing in common. Although both are inherited genetic disorders, one causes thick mucus buildup in the lungs, making it progressively harder ...